Severe coronavirus disease 2019 (COVID‐19) pneumonia patients treated successfully with a combination of lopinavir/ritonavir plus favipiravir: Case series

Severe coronavirus disease 2019 (COVID‐19) pneumonia patients treated successfully with a combination of lopinavir/ritonavir plus favipiravir: Case series

Key Clinical Message The combination therapy of Lopinavir/Ritonavir plus Favipiravir might be a treatment option for patients with COVID‐19. Serum ferritin levels and lymphocytopenia are promising markers for disease severity and disease progression that are commonly available in general clinical pr...

Полное описание

Библиографические подробности
Главные авторы: Hayato Koba, Taro Yoneda, Tomoya Kaneda, Tsukasa Ueda, Hideharu Kimura, Kazuo Kasahara
Формат: Статья
Язык:English
Опубликовано: Wiley 2020-12-01
Серии:Clinical Case Reports
Предметы:
COVID‐19
favipiravir
ferritin
Lopinavir
lymphocytopenia
ritonavir
Online-ссылка:https://doi.org/10.1002/ccr3.3358

Internet

https://doi.org/10.1002/ccr3.3358

Схожие документы